Drug formulations intended for the global market should be tested for stability under tropical climatic conditions

European Journal of Clinical Pharmacology

Volumn 59, Issue 2, 2003, Pages 135-141

  Risha, P G ^a   Vervaet, C ^b   Vergote, G ^b   Van Bortel, L ^c   Remon, J P ^b  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Bioavailability; Drug content; In vitro dissolution; Stability; Tropical

Indexed keywords

C FLOX; CIPRODAC; CIPROFED; CIPROFLOXACIN; CIPROKIN; DICLO; DICLOFENAC; DICLOFLAME; RECIPRO; REMETHAN; TYFLOX;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG MARKETING; DRUG QUALITY; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HUMAN; HUMAN EXPERIMENT; HUMIDITY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; TANZANIA; TROPIC CLIMATE; WORLD HEALTH ORGANIZATION;

EID: 0037715298     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0587-1     Document Type: Article

References (19)

1. Mohamad H, Aiache J-M, Renoux R, Mougin P, Kantelep J-P (1987) Study on the biopharmaceutical stability of medicines IV: application to tetracycline hydrochloride capsules. In vivo study. STP Pharma 3:407-411
2. Babu JR, Pandit JK (1999) Effects of aging on the dissolution stability of glibenclamide β-cyclodextrin complex. Drug Dev Ind Pharm 25:1215-1219
3. Saville DJ (2001) Influence of storage on in vitro release of ibuprofen from sugar coated tablets. Int J Pharm 224:39-49
4. Hogerzeil HV, De Goeje MJ, Abu-Reid IO (1991) Stability of essential drugs in Sudan. Lancet 338:754
5. Nazerali H, Muchemwa T, Hogerzeil HV (1996) The quality and stability of essential drugs in tropical climates (Zimbabwe). WHO/DAP/94.16. WHO, Geneva
6. Matthews RB (1999) Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 25:831-856
7. Pandit JK, Tripathi MK, Babu JR (1997) Effects of disintegrants on the dissolution stability of solid oral dosage forms. Pharmazie 52:538-540
8. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, Remon JP (2002) In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop Med Int Health 7:701-707
9. United States Pharmacopoeia Convention (2000) The United States Pharmacopeia 24 NF19. Rockville
10. Limberg M, Buggé C (1994) Tear concentration of topically applied ciprofloxacin. Cornea 13:496-499
11. Giagoudakis G, Markantonis SL (1998) An alternative high performance liquid-chromatographic method for the determination of diclofenac and flurbiprofen in plasma. J Pharm Biomed Anal 17:897-901
12. max for absorption rates in investigations of bioequivalence. Int J Clin Pharmacol Ther Toxicol 29:394-399
13. Hauschke D, Steinijans VW, Diletti E (1990) A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28:72-78
14. European Agency for the Evaluation of Medicinal products (EMEA), Committee for Proprietary Medicinal Products (2001) Note for guidance on investigation of bioavailability and bioequivalence. London, July
15. Kamba M, Seta Y, Kusai A, Nishimura K (2002) Comparison of the mechanical destructive force in the small intestine of dog and human. Int J Pharm 237:139-149
16. Yu LX, Wang JT, Hussain AS (2002) Evaluation of USP apparatus 3 for dissolution testing of immediate-release products. AAPS Pharm Sci 4
17. Gouda WH, Moustafa MA, Al-Shora I (1987) Effect of storage on nitrofurantoin solid dosage forms. Int J Pharm 18:213-215
18. Murthy KS, Ghebre-Selassie I (1993) Current perspectives on the dissolution stability of solid oral dosage forms. J Pharm Sci 82:113-126
19. Terhaag B, Hoffmann A, Barkworth M, Venss-Cappell, B (2000) Bioavailability of a new effervescent tablet of diclofenac. Int J Pharmacol Ther 38:546-551